PHOENIX, AZ—January 18, 2018 – The Arizona Health Care Cost Containment System (AHCCCS) received 1115 Waiver Amendment approval from the Centers for Medicare and Medicaid Services (CMS) to implement community engagement requirements for some able bodied AHCCCS members ages 19 to 49, and to limit retroactive coverage for some applicants to the beginning of the month in which the Medicaid application is filed. Continue reading
Author Archive: AZBio
NAU-TGen study finds West Nile Virus now a permanent part of Arizona ecosystem
New technology allows better tracking of potentially deadly infectionContinue reading
New Mayo Clinic-ASU MedTech Accelerator opens applications
The Mayo Clinic-ASU MedTech Accelerator, a collaboration between Mayo Clinic and Arizona State University that is designed specifically for medical device and health care technology companies, is now accepting applications.Continue reading
HTG Molecular Announces Executive Transition Plan
Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019
John Lubniewski, President and Chief Operating Officer, appointed as successorContinue reading
Fighting Human Disease with Birth Control… for Mosquitoes
Researchers at the University of Arizona have discovered a protein that prevents mosquitoes from hatching, opening the possibility of developing new drugs that could act as birth control for mosquito populations.Continue reading
Flinn Foundation Awards Critical Path Institute and TGen North a New Grant to Develop and Pilot a System to Respond to Antimicrobial Resistance TUCSON, Ariz., January 8
Critical Path Institute (C-Path) and Flagstaff, Arizona-based TGen North — the Pathogen and Microbiome Division of the Translational Genomics Research Institute (TGen) — have received a Phase 1 Concept Validation grant from the Flinn Foundation, of $400,000 over 12 months, to develop and pilot a framework enabling the state institutions to be more responsive to antimicrobial resistance. Working as partners in this venture, C-Path and TGen, an affiliate of City of Hope, will solidify requirements among multiple stakeholders and develop an integrated deployment plan for a statewide Healthcare Associated Antimicrobial Resistant Microbe genomic surveillance system, dubbed Prevent HAARM.Continue reading
Essential nutrient may help fight Alzheimer’s across generations
In a new study, researchers at the Biodesign Institute explore a safe and simple treatment for one of the most devastating and perplexing afflictions: Alzheimer’s disease.Continue reading
Rowpar Pharmaceuticals CEO Shares Insights in Chief Executive Magazine
Jim Ratcliff shares what is like expanding into China during a Trade War.Continue reading